The Wall Street Journal reported Pfizer cut the number of vaccines it planned to ship in 2020.<br />According to Business Insider, this is due to supply chain delays.<br />Sources say Pfizer sourced materials and set up supply chains while developing a vaccine.<br />This is an "unprecedented" move in the world of medicine and vaccine development.<br />But Pfizer and BioNtech maintain they will produce 1.3 billion doses by the end of 2021.<br />The company says there is no change to Pfizer's vaccine commitment to the US, however.
